05/03/2024 8:34 PM | Davis Aaron I. (Reporting) MVA Investors, LLC (Reporting) Tango Therapeutics (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
05/03/2024 8:32 PM | MVA Investors, LLC (Reporting) Tango Therapeutics (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
05/02/2024 8:31 PM | MVA Investors, LLC (Reporting) Tango Therapeutics (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
05/01/2024 8:32 PM | MVA Investors, LLC (Reporting) Tango Therapeutics (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
04/29/2024 3:17 PM | Tango Therapeutics (Filer)
| Form DEF 14A | |
04/17/2024 3:53 PM | Tango Therapeutics (Filer)
| Form PRE 14A | |
04/08/2024 7:46 AM | Southpoint Capital Advisors LP (Filed by) Tango Therapeutics (Subject)
| Form SC 13G/A | |
|
03/18/2024 7:27 AM | Tango Therapeutics (Filer)
| Form S-8 Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans | |
03/18/2024 6:19 AM | Tango Therapeutics (Filer)
| Form 10-K Annual report pursuant to Section 13 or 15(d) | |
03/18/2024 6:08 AM | Tango Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
02/21/2024 4:52 PM | Tango Therapeutics (Issuer) Third Rock Ventures GP IV, L.P. (Reporting) Third Rock Ventures IV, L.P. (Reporting) TRV GP IV, LLC (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
02/21/2024 11:32 AM | Tango Therapeutics (Subject) Third Rock Ventures IV, L.P. (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
02/09/2024 8:49 AM | FMR LLC (Filed by) Tango Therapeutics (Subject)
| Form SC 13G/A | |
02/08/2024 8:04 PM | Crystal Adam (Reporting) Tango Therapeutics (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
02/08/2024 8:08 PM | Beckman Daniella (Reporting) Tango Therapeutics (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
02/08/2024 8:09 PM | Barry Douglas (Reporting) Tango Therapeutics (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
02/08/2024 8:14 PM | Tango Therapeutics (Issuer) Weber Barbara (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
02/07/2024 6:00 AM | Tango Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
11/08/2023 6:29 AM | Tango Therapeutics (Filer)
| Form 10-Q General form for quarterly reports under Section 13 or 15(d) | |
11/08/2023 6:07 AM | Tango Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
11/02/2023 3:49 PM | Crystal Adam (Reporting) Tango Therapeutics (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
10/18/2023 4:23 PM | BCTG Holdings, LLC (Filed by) Tango Therapeutics (Subject)
| Form SC 13D/A | |
10/17/2023 6:41 PM | Boxer Asset Management Inc. (Reporting) Boxer Capital, LLC (Reporting) Davis Aaron I. (Reporting) LEWIS JOSEPH (Reporting) MVA Investors, LLC (Reporting) Tango Therapeutics (Issuer)
| Form 4/A | |
10/17/2023 5:04 PM | Boxer Asset Management Inc. (Reporting) Boxer Capital, LLC (Reporting) Davis Aaron I. (Reporting) LEWIS JOSEPH (Reporting) MVA Investors, LLC (Reporting) Tango Therapeutics (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
10/16/2023 2:33 PM | EcoR1 Capital, LLC (Filed by) Tango Therapeutics (Subject)
| Form SC 13G/A | |
10/16/2023 2:42 PM | EcoR1 Capital, LLC (Reporting) Tango Therapeutics (Issuer)
| Form 3 Initial statement of beneficial ownership of securities | |
10/11/2023 8:22 PM | Boxer Asset Management Inc. (Reporting) Boxer Capital, LLC (Reporting) Davis Aaron I. (Reporting) LEWIS JOSEPH (Reporting) MVA Investors, LLC (Reporting) Tango Therapeutics (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
10/11/2023 6:22 PM | Boxer Asset Management Inc. (Reporting) Boxer Capital, LLC (Reporting) Davis Aaron I. (Reporting) LEWIS JOSEPH (Reporting) MVA Investors, LLC (Reporting) Tango Therapeutics (Issuer)
| Form 4/A | |
10/10/2023 8:42 PM | MVA Investors, LLC (Reporting) Tango Therapeutics (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
10/10/2023 8:43 PM | Boxer Capital, LLC (Reporting) Tango Therapeutics (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
09/21/2023 4:16 PM | EcoR1 Capital, LLC (Filed by) Tango Therapeutics (Subject)
| Form SC 13G | |
09/11/2023 11:15 PM | Tango Therapeutics (Filer)
| Form EFFECT | |
09/11/2023 7:23 AM | FMR LLC (Filed by) Tango Therapeutics (Subject)
| Form SC 13G/A | |
09/01/2023 6:34 AM | Tango Therapeutics (Filer)
| Form S-3 Registration statement under Securities Act of 1933 | |
08/30/2023 5:04 AM | Tango Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
08/24/2023 3:10 PM | Tango Therapeutics (Filer)
| Form D Notice of Exempt Offering of Securities | |
08/22/2023 3:15 PM | Tango Therapeutics (Issuer) Third Rock Ventures GP VI, L.P. (Reporting) Third Rock Ventures VI, L.P. (Reporting) TRV GP VI, LLC (Reporting)
| Form 3 Initial statement of beneficial ownership of securities | |
08/21/2023 3:16 PM | Nextech Crossover I GP S.a r.l. (Filed by) Tango Therapeutics (Subject)
| Form SC 13G | |
08/16/2023 3:40 PM | BCTG Holdings, LLC (Filed by) Tango Therapeutics (Subject)
| Form SC 13D/A | |
08/15/2023 8:34 PM | Boxer Asset Management Inc. (Reporting) Boxer Capital, LLC (Reporting) Davis Aaron I. (Reporting) LEWIS JOSEPH (Reporting) MVA Investors, LLC (Reporting) Tango Therapeutics (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
08/10/2023 6:24 AM | Tango Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
Conflict In Israel Sends Gold Soaring ???? Here’s How To Get Your Share (Ad) The latest flare-up between Israel and Palestinian militants has sent gold prices surging.
Why? Because savvy investors know the endgame of the elites at play…
Geopolitical crises breed uncertainty — and gold thrives on uncertainty.
See why the elites are pouring billions into gold. |
08/07/2023 6:57 AM | Tango Therapeutics (Filer)
| Form 10-Q General form for quarterly reports under Section 13 or 15(d) | |
08/07/2023 6:25 AM | Tango Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
06/08/2023 8:36 PM | Borisy Alexis (Reporting) Tango Therapeutics (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
06/08/2023 8:39 PM | Calhoun Lesley Ann (Reporting) Tango Therapeutics (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
06/08/2023 8:40 PM | Rothenberg Mace (Reporting) Tango Therapeutics (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
06/08/2023 8:32 PM | Davis Aaron I. (Reporting) Tango Therapeutics (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
06/08/2023 8:33 PM | Peters Malte (Reporting) Tango Therapeutics (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
06/08/2023 8:34 PM | Huber Reid M (Reporting) Tango Therapeutics (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
06/07/2023 3:49 PM | Tango Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
05/09/2023 6:31 AM | Tango Therapeutics (Filer)
| Form 10-Q General form for quarterly reports under Section 13 or 15(d) | |
05/09/2023 6:22 AM | Tango Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |